{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "September 2018: 67-year-old woman presented with chest pain and a history of hypertension diagnosed a dozen years prior.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "67-year-old woman presented with chest pain",
              "onset": "September 2018"
            }
          ],
          "diagnoses": [
            {
              "code": "31599001",
              "label": "Hypertension",
              "status": "historical",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Chest CT showed a lesion in the right upper lung with mediastinal lymph node enlargement.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Lung CT",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "lesion in the right upper lung with mediastinal lymph node enlargement"
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Diagnosed with stage IV lung adenocarcinoma.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0678222",
              "label": "Adenocarcinoma of lung",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Next-generation sequencing (NGS) showed EGFR exon 19 L747-P753 deletion and TP53 exon 8 mutation. Fluorescence in situ hybridization (FISH) showed no alterations in ALK, BRAF, and MET genes.",
        "clinical_data": {
          "labs": [
            {
              "test": "Next Generation Sequencing",
              "finding": "EGFR exon 19 L747-P753 deletion",
              "timestamp": null
            },
            {
              "test": "Next Generation Sequencing",
              "finding": "TP53 exon 8 mutation",
              "timestamp": null
            },
            {
              "test": "Fluorescence in situ hybridization",
              "finding": "no alterations in ALK, BRAF, and MET genes",
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Initiated first-line gefitinib (250 mg/day) therapy for 6 months.",
        "clinical_data": {
          "medications": [
            {
              "drug": "gefitinib",
              "dosage": "250 mg/day",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "April 2019: Follow-up after treatment with gefitinib.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1307119",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Patient developed progressive dyspnea and chest ultrasonography showed massive right-side pleural effusion.",
        "clinical_data": {
          "imaging": [
            {
              "type": "273720007",
              "body_part": "Right lung",
              "modality": "Ultrasound",
              "finding": "Massive pleural effusion",
              "impression": "Massive pleural effusion"
            }
          ],
          "HPI": [
            {
              "summary": "Progressive dyspnea"
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "Patient discontinued gefitinib.",
        "clinical_data": {
          "medications": [
            {
              "drug": "gefitinib",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "May 2019: Patient began treatment with osimertinib (80 mg/day) as second-line therapy.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1705639",
              "dosage": "80 mg/day",
              "frequency": "daily",
              "modality": "oral",
              "start_date": "2019-05",
              "end_date": null,
              "indication": "second-line therapy"
            }
          ]
        }
      }
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "node_step_index": 9,
        "content": "Patient received indwelling pleural catheter treatment for malignant pleural effusion.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Indwelling Pleural Catheter Placement",
              "approach": "percutaneous",
              "location": "pleural cavity",
              "outcome": "treatment for malignant pleural effusion"
            }
          ],
          "diagnoses": [
            {
              "code": "C0016562",
              "label": "Malignant pleural effusion",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N11",
      "label": "Step 11",
      "customData": {
        "node_id": "K",
        "node_step_index": 10,
        "content": "Tumor cells were detected in the pleural effusion cell block. PD-L1 22C3 tumor proportion score was 80%. EGFR Exon19 deletions were detected in the pleural effusion cell block based on EGFR amplification refractory mutation system\u2013polymerase chain reaction (ARMS-PCR) and plasma ctDNA NGS analysis.",
        "clinical_data": {
          "labs": [
            {
              "test": "Pleural Effusion Cell Block",
              "value": "Tumor cells detected",
              "flag": "abnormal"
            },
            {
              "test": "PD-L1 22C3 Tumor Proportion Score",
              "value": "80%",
              "unit": "%"
            },
            {
              "test": "EGFR Exon19 deletions",
              "value": "Detected",
              "flag": "abnormal"
            }
          ]
        }
      }
    },
    {
      "id": "N12",
      "label": "Step 12",
      "customData": {
        "node_id": "L",
        "node_step_index": 11,
        "content": "Osimertinib was discontinued due to poorly controlled malignant pleural effusion.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1705873",
              "end_date": null
            }
          ],
          "diagnoses": [
            {
              "code": "C0032242",
              "label": "Pleural Effusion, Malignant",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N13",
      "label": "Step 13",
      "customData": {
        "node_id": "M",
        "node_step_index": 1,
        "clinical_data": {}
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient with chest pain and hypertension underwent chest CT."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Chest CT findings led to diagnosis of stage IV lung adenocarcinoma."
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Lung adenocarcinoma diagnosis prompted next-generation sequencing (NGS) and fluorescence in situ hybridization (FISH) testing.",
        "transition_event": {
          "trigger_type": "diagnosis",
          "trigger_entities": [
            "C0678222"
          ],
          "change_type": "addition",
          "target_domain": "lab"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "NGS and FISH results led to initiation of first-line gefitinib therapy.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Follow-up after 6 months of gefitinib treatment."
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Patient developed progressive dyspnea and chest ultrasonography showed massive right-side pleural effusion.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0013404"
          ],
          "change_type": "progression",
          "target_domain": "symptom"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Progressive dyspnea and pleural effusion led to discontinuation of gefitinib.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0013404"
          ],
          "change_type": "discontinuation",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Discontinuation of gefitinib led to initiation of second-line osimertinib therapy.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1307119"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N9",
      "to": "N10",
      "data": {
        "edge_id": "I_to_J",
        "branch_flag": true,
        "content": "Treatment with osimertinib and indwelling pleural catheter placement for malignant pleural effusion."
      }
    },
    {
      "from": "N10",
      "to": "N11",
      "data": {
        "edge_id": "J_to_K",
        "branch_flag": true,
        "content": "Pleural effusion cell block analysis, PD-L1 testing, and EGFR Exon19 deletion analysis were performed.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [],
          "change_type": "addition",
          "target_domain": "lab"
        }
      }
    },
    {
      "from": "N11",
      "to": "N12",
      "data": {
        "edge_id": "K_to_L",
        "branch_flag": true,
        "content": "Poorly controlled malignant pleural effusion despite osimertinib therapy.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "C0032242"
          ],
          "change_type": "progression"
        }
      }
    }
  ]
}